Pune, India -- (SBWire) -- 05/29/2018 --EMEA Cardiac Valve Market - Insights
Cardiac valve or heart valve allows blood to flow in only one direction through the heart; human heart is made of four valves. A cardiac valve opens or closes compulsory on differential blood pressure on each side.
Get Illustrious Discount @ https://www.marketresearchfuture.com/check-discount/610 .
The market is driven by increasing number of people with cardiovascular diseases and increasing number of cardiac surgery. Additionally, increasing prevalence of diabetes and obesity, adoption of deskbound lifestyle, rising geriatric population, and excessive use of tobacco and alcohol boost the market growth. On the other hand, higher cost of treatment methods may hamper the growth of the Europe and the Middle East & Africa cardiac valve market.
The EMEA cardiac valve market is expected to grow at a CAGR of 6.5% during the forecasted period.
Top Vendors of EMEA Cardiac Valve Market Research Report:
Medtronic, Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK HealthCare (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil)
EMEA Cardiac Valve - Segmentation
The EMEA cardiac valve market is segmented on the basis of types, by diseases, by treatment, and by end users.
On the basis of types the market is segmented into trans-catheter heart valve, tissue heart valve, and mechanical heart valve, others.
On the basis of disease, the market is segmented into aortic valve replacement, heart valve disease, mitral valve stenosis, and others.
On the basis of treatments, it is segmented into valve replacement, valve repair, and others.
On the basis of end users, the markets segmented into cardiac research institute, hospital & clinics, and others.
Avail Premium Sample copy @ https://www.marketresearchfuture.com/sample_request/610 .
EMEA Cardiac Valve Market - Regional Analysis
The Europe is the second major contributor to the global cardiac valve market. Total Europe and the Middle East & Africa cardiac valve market in 2016 was approximately USD 15 million. Germany and France are the major contributor to this market due to a huge number of patient with different cardiovascular diseases. About 9.2% of total population in France have cardiovascular diseases, which is the major factor responsible for the growth of the market.
The Middle East & Africa is expected to hold a least market share owing to less availability of medical facilities, and less development in healthcare domain.
TOC of EMEA Cardiac Valve Market Research Report:
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Drivers
4.2 Restraints
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Supply Chain Analysis
6. Europe, Middle East & Africa Cardiac Valve Market, By Type
….TOC CONTINUED
Get Customized Report, Ask to Expertise @ https://www.marketresearchfuture.com/enquiry/610 .
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Cardiac Valve Market 2018 Dynamics; Superior Growth at a CAGR of 6.5%: By Types Trans-Catheter Heart Valve, Tissue Heart Valve, Etc. – Worldwide Forecast Till 2023